GENERIC 20032845

Download in:

Switch to

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0001554, umls-concept:C0007131, umls-concept:C0181090, umls-concept:C0205462, umls-concept:C0302614, umls-concept:C1273870, umls-concept:C1706050
pubmed:issue	10
pubmed:dateCreated	2009-12-24
pubmed:abstractText	Currently the management of non-small cell lung cancer with first line chemotherapy is dependent on the histology. The growth of morbid anatomy laboratories and molecular biology, alongside the rapid expansion of new therapies, is necessary for the selection of patients according to predictive criteria of efficacy and tolerance, allowing definition of a made to measure treatment.
pubmed:language	fre
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8408032
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1776-2588
pubmed:author	pubmed-author:BennounaJJ, pubmed-author:MilanoGG, pubmed-author:PlanchardDD
pubmed:issnType	Electronic
pubmed:volume	26
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1097-106
pubmed:meshHeading	pubmed-meshheading:20032845-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:20032845-Humans, pubmed-meshheading:20032845-Lung Neoplasms
pubmed:year	2009
pubmed:articleTitle	[Towards a histologically guided management for NSCLC].
pubmed:affiliation	Laboratoire d'Oncopharmacologie, Centre Antoine Lacassagne, Nice, France. gerard.milano@cal.nice.fnclcc.fr
pubmed:publicationType	Journal Article, English Abstract, Review